ToxGenSolutions BV (TGS) addresses the transition from a one-dimensional cause-and-effect toxicity association to a systems-based safety assessment paradigm that reveals the complex multidimensional relationships between exposure, biological response, and human health outcome. TGS applies the breadth of technologies, systems, and pathways of toxicity and common nodes of toxicity developed by the Netherlands ToxicoGenomics Center (2008-2013) and representing the core promise and value of the applied systems toxicology paradigm.
TGS 4 YOU
1. HIGHER RELEVANCE AND REVENUES
TGS provides the next-generation safety assessment methods allowing for testing and assessing faster, more economically, and with higher relevance for human safety and health, while using far fewer animals than current safety assessment methods.
2. AN APPLIED SYSTEMS TOXICOLOGY APPROACH
TGS offers a pallet of novel toxicogenomics-based test systems, expertise and intellectual property related to barrier toxicity, carcinogenicity, immunotoxicity and reproductive/developmental toxicity.
3. TESTING AND ASSESSMENT BASED ON MECHANISTIC UNDERSTANDING
The TGS products are proprietary mechanism-based gene signatures for identification and classification of toxicants during screening, product development and safety assessment.
4. FOCUS ON YOUR NEEDS
TGS develops testing and assessment strategies for, and with, you to assure optimal coverage of the customer needs defined by the nature of the test substances, the intended application, product development status or legislation.